Literature DB >> 6966313

Induction of tolerance to 1-fluoro-2,4-dinitrobenzene contact sensitivity with hapten-modified lymphoid cells. II. Selective tolerance in F1 mice of T cell subsets recognizing 1-fluoro-2,4-dinitrobenzene associated with parental major histocompatibility complex antigens.

P J Conlon, J W Moorhead, S D Miller, H N Claman.   

Abstract

F1 animals were tolerized to 1-fluoro-2,4-dinitrobenzene (DNFB) contact sensitivity with parentally derived, in vitro hapten-modified spleen cells. This tolerant state was found, upon adoptive transfer to naive parental strain recipients, to affect only that T cell subpopulation that recognized the parental haplotype of the cell used as the tolerogen, and did not inhibit the ability of the remaining T cell subset to confer immunity. This demonstrates that this tolerant state involves the inactivation of a cell required for the expression of contact sensitivity by recognizing DNFB in association with self major histocompatibility complex gene products.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6966313      PMCID: PMC2185825          DOI: 10.1084/jem.151.4.959

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  The induction of hapten-specific T cell tolerance by using hapten-modified lymphoid cells. I. Characteristics of tolerance induction.

Authors:  S D Miller; H N Claman
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

2.  The induction of hapten-specific T cell tolerance using hapten-modified lymphoid membranes. II. Relative roles of suppressor T cells and clone inhibition in the tolerant state.

Authors:  S D Miller; M S Sy; H N Claman
Journal:  Eur J Immunol       Date:  1977-03       Impact factor: 5.532

3.  Tolerance: two pathways of negative immunoregulation in contact sensitivity to DNFB.

Authors:  H N Claman; S D Miller; J W Moorhead
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1977

4.  A splenic requirement for the generation of suppressor T cells.

Authors:  M S Sy; S D Miller; H B Kowach; H N Claman
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

5.  H-2 gene complex restricts transfer of delayed-type hypersensitivity in mice.

Authors:  J F Miller; M A Vadas; A Whitelaw; J Gamble
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

6.  Immune suppression with supraoptimal doses of antigen in contact sensitivity. I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide.

Authors:  M S Sy; S D Miller; H N Claman
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

7.  H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;.

Authors:  R M Zinkernagel; P C Doherty
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

8.  Restricted helper function of F1 hybrid T cells positively selected to heterologous erythrocytes in irradiated parental strain mice. II. Evidence for restrictions affecting helper cell induction and T-B collaboration, both mapping to the K-end of the H-2 complex.

Authors:  J Sprent
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

9.  Restricted helper function of F1 hybrid T cells positively selected to heterologous erythrocytes in irradiated parental strain mice. I. Failure to collaborate with B cells of the opposite parental strain not associated with active suppression.

Authors:  J Sprent
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

10.  Cell interactions between histoincompatible T and B lymphocytes. II. Failure of physiologic cooperative interactions between T and B lymphocytes from allogeneic donor strains in humoral response to hapten-protein conjugates.

Authors:  D H Katz; T Hamaoka; B Benacerraf
Journal:  J Exp Med       Date:  1973-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.